DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief AI Scientist

BROSSARD, Quebec, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in applying techniques in Artificial Intelligence (AI) for the early detection of eye-related health issues, is pleased to announce the appointment of Dr. Ismail Ben Ayed, as Chief Artificial Intelligence (AI) Scientist.

DIAGNOS, a company known for its innovative work in healthcare, has announced the appointment of Dr. Ismail Ben Ayed as its new Chief Artificial Intelligence (AI) Scientist. This strategic move aims to enhance the company’s capabilities in developing AI-driven solutions for the healthcare sector.

Dr. Ben Ayed brings a wealth of experience and expertise in the AI field, particularly in applying machine learning algorithms to practical problems. His background encompasses both academic achievements and practical applications, making him a pivotal addition to the DIAGNOS team. The company is confident that his leadership and insights will significantly bolster its research and development efforts.

One of the key goals set forth by DIAGNOS is to leverage Dr. Ben Ayed’s expertise to further accelerate innovation in healthcare technologies. The utilization of AI technologies in healthcare has the potential to revolutionize diagnostics, improve patient care, and streamline operational processes within medical institutions. With Dr. Ben Ayed at the helm of AI initiatives, DIAGNOS is positioned to enhance its product offerings and provide cutting-edge solutions.

In his previous roles, Dr. Ben Ayed has been involved in various high-impact research projects, focusing on optimizing machine learning systems. His successful track record will support DIAGNOS in staying at the forefront of a rapidly evolving industry. The integration of AI in healthcare is not simply a trend; it is a necessary transition towards more efficient and effective patient care.

DIAGNOS has positioned itself as a leader in artificial intelligence applications in healthcare, and the addition of Dr. Ben Ayed will play a critical role in driving this vision forward. The company's commitment to innovation is reflected in its ongoing investment in top-tier talent, which is essential for leading the way in AI-enhanced healthcare solutions.

Overall, Dr. Ismail Ben Ayed's appointment is expected to catalyze advancements in AI technologies at DIAGNOS, ultimately contributing to better healthcare outcomes. As the demand for AI in the healthcare sector continues to grow, DIAGNOS is poised to make significant strides under Dr. Ben Ayed's leadership.